Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.
Inceptive has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in September 2023.
Inceptive's investors include Andreessen Horowitz, NVIDIA, S32, Obvious Ventures.
Inceptive is headquartered in Palo Alto, United States.
Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.
Inceptive is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inceptive — Funding & Investors." VCBacked, September 7, 2023, https://www.vcbacked.co/company/inceptive. Accessed July 20, 2026.
VCBacked. (2023). Inceptive — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/inceptive
{{cite web |title=Inceptive — Funding & Investors |url=https://www.vcbacked.co/company/inceptive |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated